10-06-2024, 11:04 PM
No worries, the government looked into it, and they've closed their investigation:
Oh wait, that's from 2019! Amazing what you can find you enter a custom date range in the search engine...
They've been playing this game for a while now.
Quote:Baxter International Inc said the U.S. Justice Department has closed an antitrust probe examining possible communication among producers of intravenous saline solutions during supply shortages that created higher prices.
Oh wait, that's from 2019! Amazing what you can find you enter a custom date range in the search engine...
Quote:Baxter, which received a grand jury subpoena in 2017 as part of the investigation, said in a filing with the U.S. Securities and Exchange Commission on Thursday that the department informed it on Nov. 30 of its decision to end the probe. Other companies that in April 2017 disclosed receiving subpoenas as part of the investigation included Pfizer Inc and ICU Medical Inc, which earlier that year had acquired Pfizer's global infusion therapy business.
https://www.reuters.com/article/business...KCN1QB25J/
Quote:While Hurricane Maria in 2017 was one of the most publicized causes for IV solution shortages in recent years, the problems began long before that storm. As the FDA stated at the time, “Although Hurricane Maria affected Baxter’s facilities in Puerto Rico, there have been limited supplies of IV fluids since 2014.” Throughout 2014, the U.S. experienced a nationwide shortage of IV solutions, specifically saline large volume intravenous solution.
https://www.hpnonline.com/surgical-criti...-shortages
Quote:Intravenous (IV) nitroglycerin continues to be in short supply in the United States, and efforts are ongoing to try to boost supplies, Baxter International and the US Food and Drug Administration (FDA) told Medscape Medical News today.
...In the past, nitroglycerin injection was manufactured by 3 companies: Luitpold/American Regent, Baxter, and Hospira. However, since the fall of 2013, Baxter has been the sole supplier to the US market because of manufacturing problems at the other 2 companies.
https://www.medscape.com/viewarticle/822691?form=fpf
Quote:Jan 21, 2013: So my home health infusion provider has notified me of a shortage of lipids for my TPN infusions. I am allocated less than a third of what I need in a week. I am quite disturbed by this developement and I wondered if any other TPN patients might be as well??
...What are others doing about this? Are you eating more? Are your lipids being rationed (I was told it was a national shortage and Baxter, the only provider of lipids in the US, is not making enough)?
https://www.inspire.com/groups/oley-foun...shortages/
They've been playing this game for a while now.
I followed the Science, and all I found was the Money.